| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 30-11-2018 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 0.75% As on (29-09-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 100.0 |
| Minimum Topup: 100.0 |
| Total Assets: 3,750.04 Cr As on 30-09-2026(Source:AMFI) |
| Turn over: 0.04% | Exit Load: Holding period <= 1 month: 0.50%; Holding period > 1 month: Nil (above exit load will be applicable from August 1, 2023) |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved
| Standard Deviation | 15.23 |
| Sharpe Ratio | 0.98 |
| Alpha | 4.56 |
| Beta | 0.79 |
| Yield to Maturity | - |
| Average Maturity | - |
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| DSP Healthcare Fund - Direct Plan - Growth | 30-11-2018 | 12.58 | 3.9 | 19.51 | 14.76 | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
43.08%
Others
16.05%
Large Cap
24.86%
Mid Cap
16.01%